Table 4.
Low-FBa group (fluid balance < 0.0L) |
Moderate-FB group (fluid balance 0.0–2.0L) |
High-FB group (fluid balance > 2.0L) |
|||
---|---|---|---|---|---|
ORb (95% CI) | p Value | OR (95% CI) | p Value | ||
Crude analysis | |||||
Primary outcome | |||||
Cardiopulmonary complications | 1.1 (0.3–3.6) | 0.880 | Refc | 3.4 (1.6–7.9) | 0.002 |
Secondary outcome | |||||
Renal complications | 1.1 (0.3–3.3) | 0.830 | Ref | 1.7 (0.8–3.9) | 0.147 |
Infectious complications | 0.8 (0.3–1.8) | 0.598 | Ref | 1.2 (0.7–2.0) | 0.605 |
Wound related complications | 0.7 (0.3–1.9) | 0.552 | Ref | 0.6 (0.3–1.2) | 0.149 |
Adjustedd analysis | |||||
Primary outcome | |||||
Cardiopulmonary complications | 1.7 (0.5–6.1) | 0.436 | Ref | 3.4 (1.5–7.6) | 0.002 |
Secondary outcome | |||||
Renal complications | 1.0 (0.5–1.7) | 0.855 | Ref | 1.7 (0.8–3.6) | 0.202 |
Infectious complications | 0.8 (0.3–1.9) | 0.571 | Ref | 1.0 (0.6–1.9) | 0.852 |
Wound-related complications | 0.7 (0.3–2.2) | 0.577 | Ref | 0.5 (0.3–1.2) | 0.109 |
aFluid balance. bOdds ratio (95% confidence interval). cThe moderate-FB group serves as reference in bi-variate analysis. dAdjusted by a weighted propensity score based on age, BMI, sex, ASA-class (classes 1–3 or 4–5), tobacco use (yes or no), alcohol intake > 7 units/week for women and > 14 units/week for men, pre-operative sepsis-2-score (classes 0–2 or 3–4), yes or no for: active cancer, cardiac co-morbidity, pulmonary co-morbidity, other co-morbidity including renal disease, liver disease or diabetes, limited postoperative treatment, and the use of vasopressors. In addition, laparotomy/laparoscopy, resection or no resection of the intestine, the diagnosis (gastrointestinal obstruction), upper perforation (gastric, jejunal or ileac), or lower perforation (colonic or rectal)